Simplex Trading’s Century Therapeutics IPSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.27K Buy
+4,100
New +$8.62K ﹤0.01% 7426
2024
Q1
Sell
-1,800
Closed -$5K 9315
2023
Q4
$5K Sell
1,800
-100
-5% -$182 ﹤0.01% 7863
2023
Q3
$3K Buy
+1,900
New +$5.05K ﹤0.01% 7907
2023
Q2
Sell
-1,500
Closed -$5K 9429
2023
Q1
$5K Buy
+1,500
New +$6.59K ﹤0.01% 8049

Other funds holding IPSC

Simplex Trading's IPSC Position: Q1 2026 in Review

Simplex Trading increased its Century Therapeutics (IPSC) stake by 277% in Q1 2026, buying an estimated $13.9K and bringing the position to 9,028 shares worth $20.4K. The position accounts for ﹤0.01% of the portfolio, ranked #6763.

Simplex Trading first reported a position in IPSC in Q2 2023 and has held it in 6 quarters since. 72 funds tracked by Wall St. Rank hold IPSC as of Q1 2026.

  • Simplex Trading held 9,028 shares of Century Therapeutics worth $20.4K as of Q1 2026.
  • Simplex Trading bought 6,631 Century Therapeutics shares in Q1 2026, an estimated $13.9K.
  • Century Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6763 holding.
  • Simplex Trading first reported a position in Century Therapeutics in Q2 2023 and has held it in 6 quarters since.
  • 72 funds tracked by Wall St. Rank held Century Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.